Paper8968085
Germline BRCA2 gene mutations in patients with apparently sporadic pancreatic carcinomas.
Goggins M and 10 others. Cancer Res, 1996. Cited by 512 papers, by iCite.
Cite this record
ConductScience Library. Germline BRCA2 gene mutations in patients with apparently sporadic pancreatic carcinomas. Papers, record 8968085. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8968085
- Cell line
- Capan-1108 papers
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Connected records1
Records in the library's other databases whose lists name this one, each read from that database's own release: up to 20 of each kind, the most connected first.
Cell lines1
Source Cell lines
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adenocarcinoma | Major topic |
| Neoplasm Proteins | Major topic |
| Pancreatic Neoplasms | Major topic |
| Transcription Factors | Major topic |
| Adult | |
| Alleles | |
| BRCA2 Protein | |
| Codon | |
| DNA Mutational Analysis | |
| DNA, Neoplasm | |
| Female | |
| Heterozygote | |
| Humans | |
| Jews | |
| Male | |
| Pancreas | |
| Pancreaticoduodenectomy | |
| Sequence Deletion | |
| Tumor Cells, Cultured |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| CA62924 | NCI NIH HHS | United States | P50CA062924 | PubMed and NIH |
Source NIH RePORTER
Cited by229
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 512 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42098138 | Pancreatic cancer. | Nat Rev Dis Primers | 2026 | https://conductscience.org/library/papers/42098138 | PubMed |
| 41735493 | Mutational profiles of spontaneous and radiation-related mammary carcinomas in a rat model of Brca1 haploinsufficiency. | Sci Rep | 2026 | https://conductscience.org/library/papers/41735493 | PubMed |
| 41681964 | Frequency of Founder Mutations in BRCA1 and BRCA2 Genes in Hereditary Breast Cancers in Poland vs. Other Countries. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/41681964 | PubMed |
| 39279378 | The Pivotal Role of Germline BRCA2 Pathogenic Variants in "Apparently Sporadic" Pancreatic Cancer. | Cancer Res | 2024 | https://conductscience.org/library/papers/39279378 | PubMed |
| 38869494 | Genome-Wide Analysis to Assess if Heavy Alcohol Consumption Modifies the Association between SNPs and Pancreatic Cancer Risk. | Cancer Epidemiol Biomarkers Prev | 2024 | https://conductscience.org/library/papers/38869494 | PubMed |
| 38829622 | Synergistic cytotoxicity of histone deacetylase and poly-ADP ribose polymerase inhibitors and decitabine in pancreatic cancer cells: Implications for novel therapy. | Oncotarget | 2024 | https://conductscience.org/library/papers/38829622 | PubMed |
| 38722139 | Unraveling noncoding DNA variants and epimutations: a paradigm shift in hereditary cancer research. | Future Oncol | 2024 | https://conductscience.org/library/papers/38722139 | PubMed |
| 38511045 | Expression Profile of KRAS and p16 in Periampullary Cancer. | Indian J Surg Oncol | 2024 | https://conductscience.org/library/papers/38511045 | PubMed |
| 37587346 | Long-molecule scars of backup DNA repair in BRCA1- and BRCA2-deficient cancers. | Nature | 2023 | https://conductscience.org/library/papers/37587346 | PubMed |
| 37232812 | Olaparib versus Placebo in Maintenance Treatment of Germline BRCA-Mutated Metastatic Pancreatic Cancer: A Cost-Utility Analysis from the Canadian Public Payer's Perspective. | Curr Oncol | 2023 | https://conductscience.org/library/papers/37232812 | PubMed |
| 37212770 | Screening for pancreatic cancer has the potential to save lives, but is it practical? | Expert Rev Gastroenterol Hepatol | 2023 | https://conductscience.org/library/papers/37212770 | PubMed |
| 37139244 | Therapeutic disruption of RAD52-ssDNA complexation via novel drug-like inhibitors. | NAR Cancer | 2023 | https://conductscience.org/library/papers/37139244 | PubMed |
| 36980574 | Pancreatic Cancer Surveillance in Carriers of a Germline Pathogenic Variant in CDKN2A. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/36980574 | PubMed |
| 36358659 | TRAIL Receptor Targeting Agents Potentiate PARP Inhibitor Efficacy in Pancreatic Cancer Independently of BRCA2 Mutation Status. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/36358659 | PubMed |
| 36315333 | The Frequency of Germline BRCA and Non-BRCA HR-Gene-Variants in a Cohort of Pancreatic Cancer Patients. | Dig Dis Sci | 2023 | https://conductscience.org/library/papers/36315333 | PubMed |
| 36029239 | Risk of Pancreatic Cancer in the Long-Term Prospective Follow-Up of Familial Pancreatic Cancer Kindreds. | J Natl Cancer Inst | 2022 | https://conductscience.org/library/papers/36029239 | PubMed |
| 35995657 | Endoplasmic stress-inducing variants in carboxyl ester lipase and pancreatic cancer risk. | Pancreatology | 2022 | https://conductscience.org/library/papers/35995657 | PubMed |
| 35884779 | Intraductal Papillary Mucinous Neoplasms in Hereditary Cancer Syndromes. | Biomedicines | 2022 | https://conductscience.org/library/papers/35884779 | PubMed |
| 35626055 | BRCA-Mutated Pancreatic Cancer: From Discovery to Novel Treatment Paradigms. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/35626055 | PubMed |
| 35309086 | Platinum-based chemotherapy for pancreatic cancer: impact of mutations in the homologous recombination repair and Fanconi anemia genes. | Ther Adv Med Oncol | 2022 | https://conductscience.org/library/papers/35309086 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| BRCA2 | 675 | PubTator's text mining | https://conductscience.org/library/genes/675 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8968085
GET https://conductscience.org/api/papers/v1/8968085/cited_by?page=2